Genmab A/S
GMABNASDAQHealthcare● Active
$24.80
$-0.35(-1.39%)
Market Cap$15.2B
P/E Ratio—
52W High$35.43
52W Low$20.225
Genmab A/S（GMAB）· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · GMAB · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $1.71B | $21.10B | $28.14B | $22.32B | $19.34B |
| Net Receivables | $1.15B | $6.69B | $4.95B | $5.71B | $3.37B |
| Inventory | $0.02B | $0.06B | $0.06B | $0.00B | $0.00B |
| Total Current Assets | $2.88B | $27.85B | $33.14B | $28.22B | $22.74B |
| PP&E Net | $0.28B | $0.26B | $1.64B | $1.32B | $0.97B |
| Goodwill | $0.35B | $2.54B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $9.10B | $12.34B | $0.10B | $0.15B | $0.25B |
| Total Assets | $12.84B | $45.81B | $35.29B | $30.12B | $24.63B |
| Liabilities | |||||
| Short-Term Debt | $0.27B | $0.00B | $0.00B | $0.00B | $0.00B |
| Accounts Payable | $1.07B | $0.00B | $0.00B | $0.00B | $0.35B |
| Total Current Liabilities | $1.42B | $5.31B | $2.48B | $1.82B | $1.57B |
| Long-Term Debt | $5.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Liabilities | $7.01B | $9.11B | $3.68B | $2.84B | $2.43B |
| Stockholders Equity | |||||
| Retained Earnings | $4.09B | $23.55B | $19.02B | $14.81B | $10.02B |
| Total Stockholders Equity | $5.83B | $36.70B | $31.61B | $27.28B | $22.20B |
| Total Liab & Equity(computed) | $12.84B | $45.81B | $35.29B | $30.12B | $24.63B |
| Debt Summary | |||||
| Total Debt | $5.43B | $1.03B | $0.77B | $0.60B | $0.42B |
| Net Debt | $3.71B | ($8.83B) | ($14.10B) | ($9.30B) | ($8.53B) |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Genmab A/S
关于Genmab A/S（GMAB）资产负债表
Genmab A/S总资产$12.84B，现金及短期投资$1.71B，总负债$7.01B，总债务$5.43B，股东权益$5.83B。
常见问题
GMAB · 4 问Genmab A/S总债务$5.43B，净债务$3.71B。
GMAB total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10